Serum visfatin level as a prognostic marker in colorectal cancer patients: A retrospective cohort study

نویسندگان
Mohammadpour, Amir Hooshang ID 1
Mehri, Soghra ID 2
Jannati, Mahdi ID 3
Elyasi, Sepideh ID 4
Ghaffarzadegan, Kamran ID 5
Raygani, Ranna ID 6
Izanloo, Azra ID 7

1 Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

3 Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

4 Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

5 Razavi Cancer Research Center, Razavi Hospital, Imam Reza International University, Mashhad, Iran

6 Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

7 Razavi Cancer Research Center, Razavi Hospital, Imam Reza International University, Mashhad, Iran

doi
10.58209/ijbc.15.1.53
چکیده

Background: Colorectal cancer is the third common cancer in women and the fourth one among men, worldwide. Identifying prognostic factors are among the current challenges in cancer management. There are some evidence that visfatin, an adipocyte-secreted peptide, plays a significant role in cancer progression, proliferation, angiogenesis, metastasis, and drug resistance. In ...

کلیدواژه‌ها
Visfatin, Colorectal cancer, Prognostic marker, Survival